Vanda Pharmaceuticals Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
VNDA Nasdaq 8731 https://www.vandapharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Announces Participation in the Jefferies 2023 Global Healthcare Conference - Jun 5th, 2023 11:00 am
Vanda Pharmaceuticals Announces Presentations at SLEEP 2023 - Jun 2nd, 2023 1:41 am
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VCA-894A, a Novel Antisense Oligonucleotide Candidate for the Treatment of Charcot-Marie-Tooth Disease, Type 2S - Jun 2nd, 2023 1:31 am
A Sea Change in Motion Sickness Therapy: Vanda Pharmaceuticals' Tradipitant Shows Promising Data in Real-world Test - May 25th, 2023 7:06 pm
Vanda Pharmaceuticals Reports Results from a Phase III study of Tradipitant in Motion Sickness - May 25th, 2023 11:00 am
Vanda Pharmaceuticals Responds to Ruling in HETLIOZ® ANDA Appeal - May 10th, 2023 6:26 pm
Vanda Pharmaceuticals Announces Presentations at DDW 2023 - May 4th, 2023 10:00 pm
Q1 2023 Vanda Pharmaceuticals Inc Earnings Call - May 4th, 2023 9:53 am
Vanda Pharmaceuticals Reports First Quarter 2023 Financial Results - May 3rd, 2023 8:01 pm
Vanda Pharmaceuticals sues U.S. government over drug trade secrets - May 2nd, 2023 10:40 pm
Vanda Pharmaceuticals Sues Federal Government for Misappropriation of Trade Secrets and Confidential Information - May 2nd, 2023 4:46 pm
Vanda Pharmaceuticals to Announce First Quarter 2023 Financial Results on May 3, 2023 - Apr 27th, 2023 10:00 pm
Calculating The Fair Value Of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) - Apr 4th, 2023 10:04 am
Court Favors Vanda In Case Against FDA Over Detail Disclosure Of Rejection Of Sleep Disorder Drug - Mar 29th, 2023 2:20 pm
Vanda Prevails in Jet Lag Litigation Against the FDA - Mar 28th, 2023 5:26 pm
Vanda Pharmaceuticals Appoints Dr. Tage Honoré to its Board of Directors - Mar 17th, 2023 11:00 am
Shareholders in Vanda Pharmaceuticals (NASDAQ:VNDA) are in the red if they invested five years ago - Feb 22nd, 2023 10:38 am
Why Vanda Pharmaceuticals Stock Crawled Higher Today - Feb 9th, 2023 11:48 pm
Vanda Pharmaceuticals seeks multiple FDA approvals while battling generic competition - Feb 9th, 2023 7:29 pm
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2022 Earnings Call Transcript - Feb 9th, 2023 7:24 pm